RDNT: RadNet Corp Broker Consensus Forecast

Brandmark of RadNet Corp (RDNT)

RadNet, Inc. (RDNT) relies on a steady patient flow driven by regular physician referrals, which generates a sustainable cash flow. Diagnostic efficiency is enhanced through partnerships with AI developers and hospital networks. This chart illustrates the market price, where the indicator stands at 95.24. Despite the scale of its MRI network, business profitability is constrained by strict insurance reimbursement limits and government tariff regulations.

RDNT (RadNet Management) Consensus Target history from 07/04/2022 to 11/11/2026
Brand item of RadNet Management

The indicator synthesizes market expectations by comparing actual revenue against the collective targets of Wall Street analysts. This metric measures the gap between the current quote and the business's fair value. For RadNet, Inc. (RDNT), this calculation reflects the capitalization of synergies derived from the implementation of AI diagnostics and hospital alliances. By analyzing changes in the consensus valuation of the security, an investor can determine if the asset is overheated. An upward curve confirms the issuer's strength, although peak values signal a risk of capital freeze.

Competing companies

HCA (hcahealthcare.com) - Fair Value Consensus|Analyst Consensus Forecast THC (Tenet Healthcare Corporation)|FMS: Broker Consensus Forecast|SOLV - Price Target Chart|EHC (Encompass) - Broker Consensus Forecast|UHS (uhsinc.com) - Consensus Target|DVA: Analyst Forecast Prices|Consensus Target OPCH|SGRY (Surgery Partners Inc) - Analyst Forecast Prices|Price Target Chart Premier Corp (PINC)|EYE (America's Best Contacts & Eyeglasses) - Fair Value Consensus|Analyst Consensus Forecast PGNY (Progyny, Inc.)|ardenthealth.com (ARDT) - Average Forecast Price|Select Medical Holdings - Analyst Consensus Forecast|ASTH - Analyst Consensus Forecast|MD (Pediatrix Medical Group) - Consensus Target|USPH: Analyst Forecast Prices|Price Target Chart The Pennant Group, Inc.|Consensus Target organogenesis.com (ORGO)|Analyst Consensus Forecast NUTX|AUNA - Average Forecast Price|Price Target Chart sbc-holdings.com SBC|EOLS: Broker Consensus Forecast|CYH: Consensus Target|The Beauty Health - Analyst Forecast Prices|mediwound.com (MDWD) - Price Target Chart|Biote - Fair Value Consensus|JYNT (The Joint Corporation) - Analyst Consensus Forecast|Analyst Consensus Forecast DocGo, Inc|Analyst Consensus Forecast PIII|Gain Therapeutics Inc. - Broker Consensus Forecast|Price Target Chart EUDA Health EUDA|BMGL: Broker Consensus Forecast|CollPlant Ltd - Analyst Consensus Forecast|Average Forecast Price Cuprina Holdings Limited|CCM (Concord Medical Services) - Consensus Target|AMS: Analyst Forecast Prices|Consensus Target MRM|ALBT: Fair Value Consensus|Analyst Consensus Forecast DHAI|Analyst Median Target Carmell Corp|Price Target Chart NewGenIvf Group Limited NIVF|ATIP: Broker Consensus Forecast|CareMax - Analyst Consensus Forecast|Kindly MD Inc (KDLY) - Consensus Target|MODV (LogistiCare) - Consensus Target|NVOS - Analyst Median Target|Price Target Chart SunLink Health Systems Inc.|BACK: Fair Value Consensus